Literature DB >> 23285826

Effects of inhaled lavender essential oil on stress-loaded animals: changes in anxiety-related behavior and expression levels of selected mRNAs and proteins.

Mizuho Takahashi1, Akiharu Yoshino, Ayako Yamanaka, Chihiro Asanuma, Tadaaki Satou, Shinichiro Hayashi, Yoshinori Masuo, Kiyomi Sadamoto, Kazuo Koike.   

Abstract

Inhalation of various essential oils elicits behavioral changes as a consequence of a complex centrally coordinated response. To understand the molecular mechanisms of action of aromatic compounds on emotional responses, we evaluated the stress-induced changes in mouse brain and the efficacy of inhaled essential oil from Lavandula officinalis (LvEO) using two approaches: a behavioral test, and examining the expression levels of selected genes {fast nerve growth factor receptor (NGFR) mRNA, activity regulated cytoskeletal-associated protein (Arc) mRNA} and proteins {galactokinase 1 (GLK1) and brain-derived neurotrophic factor (BDNF)}. Animals were randomly divided into 4 groups depending on the treatment given: stress (-)/H20, stress (-)/LvEO, stress (+)/H2O, and stress (+)/LvEO group. For behavioral testing, using an elevated plus-maze test, significant anxiolytic-like effects were seen in both the stress (-)/LVEO and stress (+)/LvEO groups, indicating that LvEO exerts anxiolytic-like effects regardless of the administration of water immersion stress. On expression analysis, the levels of NGFR and Arc mRNA were significantly lower in animals subjected to stress. Inhalation of LvEO, however, reversed this change, thus suggesting that LvEO negates the impact of stress on gene expression levels. Meanwhile, significant decreases in expression levels were also observed in the stress (-)/LvEO group, which implies that LvEO, when given in a stress-free situation, may act as a stress stimulus. Taken together, our data suggest that inhalation of LvEO exerts bidirectional influences in the central nervous system (CNS) of animals, either attenuating the effects of stress or acting as a stressor, depending on the subject state.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23285826

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  6 in total

1.  Aroma oil therapy in palliative care: a pilot study with physiological parameters in conscious as well as unconscious patients.

Authors:  Melanie Goepfert; Patrick Liebl; Natalie Herth; Giancarlo Ciarlo; Jens Buentzel; Jutta Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-20       Impact factor: 4.553

2.  CUL3 Deficiency Causes Social Deficits and Anxiety-like Behaviors by Impairing Excitation-Inhibition Balance through the Promotion of Cap-Dependent Translation.

Authors:  Zhaoqi Dong; Wenbing Chen; Chao Chen; Hongsheng Wang; Wanpeng Cui; Zhibing Tan; Heath Robinson; Nannan Gao; Bin Luo; Lei Zhang; Kai Zhao; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2019-11-25       Impact factor: 17.173

Review 3.  Smell and Stress Response in the Brain: Review of the Connection between Chemistry and Neuropharmacology.

Authors:  Yoshinori Masuo; Tadaaki Satou; Hiroaki Takemoto; Kazuo Koike
Journal:  Molecules       Date:  2021-04-28       Impact factor: 4.411

4.  Anti-stress and neuronal cell differentiation induction effects of Rosmarinus officinalis L. essential oil.

Authors:  Myra O Villareal; Ayumi Ikeya; Kazunori Sasaki; Abdelkarim Ben Arfa; Mohamed Neffati; Hiroko Isoda
Journal:  BMC Complement Altern Med       Date:  2017-12-22       Impact factor: 3.659

5.  The Protective Effect of Lavender Essential Oil and Its Main Component Linalool against the Cognitive Deficits Induced by D-Galactose and Aluminum Trichloride in Mice.

Authors:  Pan Xu; Kezhu Wang; Cong Lu; Liming Dong; Li Gao; Ming Yan; Silafu Aibai; Yanyan Yang; Xinmin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-26       Impact factor: 2.629

6.  Essential Oils in Experimental Models of Neuropsychiatric Disorders: A Systematic Review.

Authors:  Luciana Cristina B Fernandes; Ianara Mendonça Costa; Marco Aurelio M Freire; Francisca Overlânia V Lima; Francisca Idalina Neta; Eudes Euler de Souza Lucena; Rodrigo Dias Alves; Jose Rodolfo Lopes P Cavalcanti; Francisco Irochima Pinheiro; Eduardo Pereira de Azevedo; Carlos Iberê A Freitas; Fausto Pierdoná Guzen
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.